USPTO 2015–2025 USPTO PatentsView US Corporation

GRAIL, INC.

USPTO PatentsView assignee record — 55 granted patents across 12 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).

55
Total patents granted
12
CPC technology areas
22.6
Avg claims per patent
+2550%
5-year filing velocity

Portfolio overview

GRAIL, INC. has been granted 55 US utility patents between 2018 and 2025, placing GRAIL, INC. at rank #6,150 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.6 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, GRAIL, INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 59.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 53 grants, compared with 2 in the 2015–2019 window — a +2550% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. GRAIL, INC.'s 22.6 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark GRAIL, INC. against peers pursuing similar technology classes.

How does GRAIL compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows GRAIL holds 55 patents — placing it at rank #6,150 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2018–2025

051015 20182019202020212022202320242025 9
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
GRAIL, INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 1.8%
2019 1 1.8%
2020 3 5.5%
2021 5 9.1%
2022 9 16.4%
2023 14 25.5%
2024 13 23.6%
2025 9 16.4%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Accelerating

Where it ranks

Overall rank by patents

#6,150

Across all tracked assignees

Innovation Score

59.7 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does GRAIL, INC. hold?
GRAIL, INC. holds 55 US granted patents filed between 2018 and 2025, spanning 12 technology areas.
What is GRAIL, INC.'s Innovation Score?
GRAIL, INC. has an Innovation Score of 59.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does GRAIL, INC. focus on?
GRAIL, INC.'s top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 45 patents. The company has filed patents in 12 CPC subclasses total.
Is GRAIL, INC.'s patent filing rate increasing or decreasing?
GRAIL, INC.'s recent filing velocity is +2550% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for GRAIL, INC.'s patents?
GRAIL, INC.'s patents average 22.6 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the GRAIL, INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope